<SEC-DOCUMENT>0001193125-24-146510.txt : 20240524
<SEC-HEADER>0001193125-24-146510.hdr.sgml : 20240524
<ACCEPTANCE-DATETIME>20240524070100
ACCESSION NUMBER:		0001193125-24-146510
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240523
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240524
DATE AS OF CHANGE:		20240524

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Guardant Health, Inc.
		CENTRAL INDEX KEY:			0001576280
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				454139254
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38683
		FILM NUMBER:		24980784

	BUSINESS ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
		BUSINESS PHONE:		855-698-8887

	MAIL ADDRESS:	
		STREET 1:		3100 HANOVER STREET
		CITY:			PALO ALTO
		STATE:			CA
		ZIP:			94304
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d843201d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:gh="http://guardanthealth.com/20240523" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-249">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2024-05-23_to_2024-05-23">0001576280</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xlink:type="simple" xlink:href="gh-20240523.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase"/> </ix:references> <ix:resources> <xbrli:context id="duration_2024-05-23_to_2024-05-23"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001576280</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-05-23</xbrli:startDate> <xbrli:endDate>2024-05-23</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-260">8-K</ix:nonNumeric></span></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt:datemonthdayyearen" id="ixv-261">May 23, 2024</ix:nonNumeric></p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-262">GUARDANT HEALTH, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:stateprovnameen" id="ixv-263">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-264">001-38683</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-265">45-4139254</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction of</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">incorporation or organization)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission<br/>File Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(IRS Employer<br/>Identification No.)</span></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-266">3100 Hanover Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-267">Palo Alto</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:stateprovnameen" id="ixv-268">California</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-269">94304</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) (Zip Code)</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="white-space:nowrap"><span style="white-space:nowrap"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-270">855</ix:nonNumeric>-<ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-271">698-8887</ix:nonNumeric></span></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, include area code)</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-272">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-273">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-274">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-275">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"/>
<td style="vertical-align:bottom"/>
<td style="width:32%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:32%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br/>Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br/>on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-276">Common Stock, $0.00001 par value per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-277">GH</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:exchnameen" id="ixv-278">The Nasdaq Global Select Market</ix:nonNumeric></td></tr></table> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2024-05-23_to_2024-05-23" format="ixt-sec:boolballotbox" id="ixv-279">&#9744;</ix:nonNumeric></p> <p style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;8.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Other Events. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On May&#160;23, 2024, Guardant Health, Inc. (the &#8220;Company&#8221;) issued a press release announcing that the U.S. Food and Drug Administration&#8217;s (the &#8220;FDA&#8221;) Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee has strongly recommended FDA approval of the Company&#8217;s Shield blood test to screen for colorectal cancer in adults age 45 and older who are at average risk for the disease. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The advisory committee panel members voted on three questions regarding the use of Shield in patients who meet the criteria specified in the proposed indication. They voted 8 to 1 favorably that there is reasonable assurance Shield is safe, 6 to 3 favorably that there is reasonable assurance Shield is effective, and 7 to 2 favorably that the benefits of Shield outweigh its risks. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The recommendation from the Advisory Committee will be considered by the FDA during its ongoing review of the premarket approval for the Shield blood test. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy of the press release is being filed as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and is incorporated by reference herein. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#8201;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:7%"/>
<td style="width:90%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit&#160;No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d843201dex991.htm">Press release of Guardant Health, Inc., dated May&#160;23, 2024. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table> <p style="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&#160;</p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:4%"/>

<td style="vertical-align:bottom"/>
<td style="width:3%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:45%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">GUARDANT HEALTH, INC.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/>
<td style="height:12pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: May&#160;24, 2024</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ John G. Saia</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">John G. Saia</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Chief Legal Officer and Corporate Secretary</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d843201dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g843201dsp5.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEWS RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FDA Advisory Committee Panel Strongly Recommends Approval of Shield<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> Blood Test
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>for Colorectal Cancer Screening as a Primary <FONT STYLE="white-space:nowrap">Non-Invasive</FONT> Screening Option </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>May 23, 2024 </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>The advisory committee offers valuable <FONT STYLE="white-space:nowrap">non-binding</FONT> recommendations
for the FDA</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Blood test offers a convenient <FONT STYLE="white-space:nowrap">non-invasive</FONT> screening option that
overcomes barriers associated with current <FONT STYLE="white-space:nowrap">non-invasive</FONT> screening tests</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><I>Shield remains on track to become the first <FONT STYLE="white-space:nowrap">FDA-approved</FONT> blood test
that meets performance requirements for Medicare coverage</I><I><SUP STYLE="font-size:75%; vertical-align:top">1</SUP></I> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>PALO
ALTO, Calif.</B> (BUSINESS WIRE) &#150; Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration (FDA)&#146;s Medical Devices
Advisory Committee has strongly recommended FDA approval of the company&#146;s Shield<SUP STYLE="font-size:75%; vertical-align:top">&#153;</SUP> blood test for colorectal cancer (CRC) screening in adults age 45 and older who are at average risk for
the disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The recommendation signals the advisory committee panel&#146;s consensus on Shield&#146;s safety and effectiveness with its proposed
intended use, and their conclusion that its benefits as a primary <FONT STYLE="white-space:nowrap">non-invasive</FONT> screening option outweigh any potential risks. The committee offers valuable perspective and
<FONT STYLE="white-space:nowrap">non-binding</FONT> recommendations for the FDA to factor in alongside other considerations during approval decisions. The FDA is expected to decide whether to approve Shield later this year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The advisory committee&#146;s strong support for the approval of Shield reinforces the crucial role that a blood test option can have in improving CRC
screening rates for those at average risk,&#148; said AmirAli Talasaz, <FONT STYLE="white-space:nowrap">co-CEO</FONT> of Guardant Health. &#147;Despite the importance of detecting colorectal cancer early, there are notable barriers that can deter
average-risk Americans from completing existing screening methods. Shield effectively detects cancer at an early stage when it is most treatable. Providing people with this blood test alongside other
<FONT STYLE="white-space:nowrap">non-invasive</FONT> stool tests can increase the rate of colorectal screening<B><I> </I></B>and potentially reduce preventable CRC deaths.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The advisory committee panel members voted on three questions regarding the use of Shield in patients who meet the criteria specified in the proposed
indication. They voted 8 to 1 favorably that there is reasonable assurance Shield is safe, 6 to 3 favorably that there is reasonable assurance Shield is effective, and 7 to 2 favorably that the benefits of Shield outweigh its risks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Colorectal cancer is the second-leading cause of cancer-related deaths in the U.S.<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> yet has a 91%
five-year survival rate when caught at stage I (localized).<SUP STYLE="font-size:75%; vertical-align:top">3</SUP> Despite this, one out of three eligible Americans &#150; 50&nbsp;million people &#150; are not being screened for CRC.<SUP
STYLE="font-size:75%; vertical-align:top">4</SUP> Current primary <FONT STYLE="white-space:nowrap">non-invasive</FONT> screening options include stool-based tests which have proven efficacy in detecting CRC; however, studies have consistently found
that barriers such as handling stool and challenges performing the test impact adherence.<SUP STYLE="font-size:75%; vertical-align:top">5,6,7,8</SUP> Shield offers patients a choice that can be completed with a simple blood draw during a routine
office visit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Sadly, 76% of deaths caused by colorectal cancer occur in individuals who are not up to date with their screening,&#148;<SUP
STYLE="font-size:75%; vertical-align:top">9</SUP> said Daniel Chung, MD, gastroenterologist at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. &#147;Clinical evidence and CRC screening guidelines acknowledge the
value of offering choice to individuals at average risk for CRC and highlight the role of patient preference in test selection and CRC screening completion.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g843201dsp5.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The panel&#146;s recommendation is based on Guardant&#146;s premarket approval (PMA) application for Shield,
including the results of the pivotal ECLIPSE study evaluating the performance of the test for detecting CRC in average-risk adults. Results from the study, published in the March 2024 issue of <U>The New </U><U>England Journal of Medicine</U>,
showed that Shield demonstrated 83% sensitivity for the detection of CRC, with 90% specificity for advanced neoplasia. This performance is within range of existing stool-based tests used as primary CRC screening options, in which overall sensitivity
ranges from 67% to 92%.<SUP STYLE="font-size:75%; vertical-align:top">10</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information about Shield for CRC screening, visit
<U>BloodBasedScreening.com</U>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About the Shield test </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Shield test is a qualitative in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA from blood collected in the
Guardant Blood Collection Kit. Shield is intended for colorectal cancer screening in individuals at average risk of the disease, age 45 years or older. Patients with an &#147;Abnormal Signal Detected&#148; may have colorectal cancer or advanced
adenomas and should be referred for colonoscopy evaluation. Shield is not a replacement for diagnostic colonoscopy or for surveillance colonoscopy in high-risk individuals. The test is performed at Guardant Health, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Guardant Health </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Guardant Health is a leading
precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care by providing critical insights into what drives disease through its advanced blood and
tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment
for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on&nbsp;<U>LinkedIn</U>,&nbsp;<U>X (Twitter)</U>&nbsp;and<U>&nbsp;Facebook</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release contains
forward-looking statements within the meaning of federal securities laws, including statements regarding the potential utilities, values, benefits and advantages of Guardant Health&#146;s liquid biopsy tests or assays, which involve risks and
uncertainties that could cause the actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions, and
actual outcomes and results could differ materially from these statements due to a number of factors. These and additional risks and uncertainties that could affect Guardant Health&#146;s financial and operating results and cause actual results to
differ materially from those indicated by the forward-looking statements made in this press release include those discussed under the captions &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operation&#148; and elsewhere in its Annual Report on Form <FONT STYLE="white-space:nowrap">10-K</FONT> for the year ended December&nbsp;31, 2023, and any current and periodic reports filed with or furnished to the Securities and Exchange
Commission thereafter. The forward-looking statements in this press release are based on information available to Guardant Health as of the date hereof, and Guardant Health disclaims any obligation to update any forward-looking statements provided
to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. These forward-looking statements should not be relied upon as representing Guardant
Health&#146;s views as of any date subsequent to the date of this press release. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g843201dsp5.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>References </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. The Shield test meets performance requirements for Medicare coverage under NCD 210.3. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. American Cancer Society. Key Statistics for Colorectal Cancer. Accessed online May&nbsp;21, 2024. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U><FONT STYLE="white-space:nowrap">https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html</FONT></U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. American Cancer Society. Survival Rates for Colorectal Cancer. Accessed online May&nbsp;21, 2024. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>https://www.cancer.org/cancer/types/colon-rectal-cancer/detection-diagnosis-staging/survival-rates.html</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">4. National Colorectal Cancer Roundtable. 80% in Every Community. <U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">https://nccrt.org/our-impact/80-in-every-community</FONT></FONT></FONT></U>. Accessed May&nbsp;21, 2024. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">5. Raymond V, Foster
G, Hong Y et al. Implementation of Blood-Based Colorectal Cancer Screening: Real-World Clinical Experience. ACG 2023 Annual Scientific Meeting Abstracts. Vancouver, BC, Canada: American College of Gastroenterology. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">6. Denberg TD, Melhado TV, Coombes JM, et al. Predictors of Nonadherence to Screening Colonoscopy. J Gen Intern Med.
<FONT STYLE="white-space:nowrap">2005;20(11):989-995.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">7. Gellad ZF, Stechuchak KM, Fisher DA, et al. Longitudinal Adherence to Fecal Occult Blood
Testing Impacts Colorectal Cancer Screening Quality. Am J Gastroenterol. 2011;106(6):1125-1134. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">8. Inadomi JM, Vijan S, Janz NK, et al. Adherence to
Colorectal Cancer Screening: A Randomized Clinical Trial of Competing Strategies. Arch Intern Med. <FONT STYLE="white-space:nowrap">2012;172(7):575-582.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">9. Doubeni, CA, et al. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association with Risk of Death. Gastroenterology. 2019 Jan;
156(1): 63&#150;74.e6. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Contact: </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Zarak
Khurshid </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">investors@guardanthealth.com </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Contact:
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Mike Weist </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">press@guardanthealth.com </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">+1 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">650-647-3643</FONT></FONT> </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gh-20240523.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/24/2024 11:23:56 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2023"
  xmlns:gh="http://guardanthealth.com/20240523"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://guardanthealth.com/20240523"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" namespace="http://xbrl.sec.gov/naics/2023" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20240523_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="gh-20240523_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>gh-20240523_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/24/2024 11:23:56 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>gh-20240523_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20231012.2 -->
<!-- Creation date: 5/24/2024 11:23:56 AM Eastern Time -->
<!-- Copyright (c) 2024 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="gh-20240523.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g843201dsp5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g843201dsp5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  B *(# 2(  A$! Q$!_\0
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##__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm139949129467824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 23, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001576280<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 23,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GUARDANT HEALTH, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">45-4139254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3100 Hanover Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Palo Alto<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">855<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">698-8887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.00001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GH<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M:V+!P_W++PA$OX+HGP<Q99(+4^81@<G2R(,K?19W6W5?5V37YXS:.UMQ4]^
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MU\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK
M>MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ
M!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.
M\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( !TXN%@'04UB@0   +$
M   0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%
M  @ '3BX6"/4!L+O    *P(  !$              ( !KP   &1O8U!R;W!S
M+V-O<F4N>&UL4$L! A0#%     @ '3BX6)E<G",0!@  G"<  !,
M     ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  =.+A8
M1YG9[4P$  "-$   &               @($."   >&PO=V]R:W-H965T<R]S
M:&5E=#$N>&UL4$L! A0#%     @ '3BX6)^@&_"Q @  X@P   T
M     ( !D P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  =.+A8EXJ[',
M   3 @  "P              @ %L#P  7W)E;',O+G)E;'-02P$"% ,4
M"  =.+A8'#AEZC\!   \ @  #P              @ %5$   >&PO=V]R:V)O
M;VLN>&UL4$L! A0#%     @ '3BX6"0>FZ*M    ^ $  !H
M ( !P1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @
M'3BX6&60>9(9 0  SP,  !,              ( !IA(  %M#;VYT96YT7U1Y
><&5S72YX;6Q02P4&      D "0 ^ @  \!,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d843201d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d843201d8k.htm">d843201d8k.htm</File>
    <File>gh-20240523.xsd</File>
    <File>gh-20240523_lab.xml</File>
    <File>gh-20240523_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d843201d8k.htm": {
   "nsprefix": "gh",
   "nsuri": "http://guardanthealth.com/20240523",
   "dts": {
    "inline": {
     "local": [
      "d843201d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "gh-20240523.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gh-20240523_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gh-20240523_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2024-05-23_to_2024-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d843201d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2024-05-23_to_2024-05-23",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d843201d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://guardanthealth.com//20240523/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-24-146510-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-24-146510-xbrl.zip
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MG"T%E:NLUA^2*U@O!,.A%T/(8.L]O2N$VZ6P5@HD*VW9\LCORFFQ>+9HV-:
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M6M0DPU91ZA3OO2SN4*/U5"!MH4) T;3@P7QN?Z@YL,1S>9T"GC[DLC!ASIT
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MQ'K^P5A1"+)*D)="^HRO11N&#_ELO91W7*HM_7LG\ETT^^T+:L]_4$L#!!0
M   ( !TXN%BVUON,N 0  '\J   3    9V@M,C R-# U,C-?<')E+GAM;-6:
M78_B-A2&[U?:_^"F-ZVT(01FMATTS(HR,RO4^1*P;=6;E4D.8-6QD6T&^/=[
M'/"*0)B%Z;:*N8#@^#U^?1['29Q<?EAFG#R#TDR*=A#7Z@$!D<B4B4D[F.N0
MZH2Q@&A#14JY%- .5J"##U=OWUS^$(;D^K;W0$(R-6:F6U&T6"QJZ9@)+?G<
M8$A=2V06D3!T];O#3^2/=7,MT@<.5 /)J#:@R&]SQM-6H]YHQO6X46MLRQ10
M&X^DU$"+G$>-LP@KGI$X;C6:K?/WI'-/;O(P@@Q9!MM:.5LI-ID:\E/R,\E5
MUU((X!Q6Y)8)*A)&.1DXR^](3R0UTN&<]*U,HT\-ZAG2VB8J9^*?EOT:6??D
M[1N"'TRDT'EI.[#IV&1C.5*\)M4$[=:;D1,%VYKEGFC1S"7QQ<5%E.\MUM>L
MK#8V$$=_W=\-DBED-$0(""W9:0K=I.:K>MO<>;3>Z>IKUM)YI#N9Y+D_HEOD
M8 W[+W350EL4QHVP&=>6.@VN;)/KK"K)H0]C8G\_]7M?VYS,J4JI,%.@W$SS
M494/@/IYHQD9NI1"9JO(JJ)KF<PS$,;]=D1Z(PPSJYX82Y7E?0E(GM;65,&X
M'4RFH8ME_?S8QS"?3PEC5C,\,#3+9AP"$FWU9Z9P[ B3U[[#@H( E@9$"JD+
M8^W_9SV^6G/=#%Z9%#+@CM\<FH:D-I'/40K,MMBT&S9!Z^3@G\]=B5-&9Z2-
MHHDI)H';T2*5*^1T!+P=E(BB[VFH@]U.;==O.9T<:VA'5#2T#:ZCDD)(JA(7
M#C<+U/9'_J9&-*,*XX7)%"<YIQXKF94F9].:+#4J50JJ'30:-3SB S)33"J$
MC24!F6OT(F?6->5V'XQ!*4COUMT^Z#*WB+.GAKSF=\:S'HU=[(&BO(=#?OD[
MK([%=$!<75P'##ML36^PN?EDB&D\EE914UU(19^.S;EW;)X O>)TGU[CE=&I
MD';$U:>U8]AA>^\-MO7<T(<)LQT5YH%F1U,KUU876KE?Q^P7SYCA38%4,ZGR
MU XPP]"5<YSB5UV9GHCP&Z&J3O0;]AW@7ST#?,LX/,RS$:C3:&[KJHYNVZOC
M=.$9IR%=]E), QNS]8WI:Z =#%)U@@>-;W VZY[A[*0I)EEO?O >&>+34)8&
MJ#K&4M,.8>PGPBYN/JJA7(A7 =R6>X)OV[*#Y]M=^:8K^7G\43TI^<SLJN%K
M".[%\ 3CGF_'TI];]4)_GJ0VE/_-9J=?FI9'\(3CCFM'\<P;BG8^Z2B@IW K
M:JI+JNC3L?%GP<4^!N%/4RE.O$G8UU67T;Y7Q\F?%98_T9\!T959-A>;:V1]
M+*P#XNH2.V#88?-GD64@.4N886)RCR=CQ:RUXYB5*:L+K,RMH^7/BLF3 COD
M *^6\D5T^QA3/8['QT^++T6H+KV77#N*_JRG[/2FI_4<U+]G61+'&Z(EWC=<
MS_Q96!E ,K<6X\9HR P_^E)R7U==;OM>'2=_5D^&BMH7K0:K;"2//MWMB*I+
M:,>HP^//^H@;8C?+9$K%!$YY5E>NK2ZL<K^.F6_K(#<9J F.O8]*+LP4Y_<9
M%2>^;W(@1'4)OFC;@?P?ED(NH[W4W&&!?6]RO<=^V;< L>0+4$L! A0#%
M  @ '3BX6!<-R_G&#P  4F    X              ( !     &0X-#,R,#%D
M.&LN:'1M4$L! A0#%     @ '3BX6&M3('<X$P  ED(  !$
M ( !\@\  &0X-#,R,#%D97@Y.3$N:'1M4$L! A0#%     @ '3BX6,9Z015!
M P  30L   \              ( !62,  &=H+3(P,C0P-3(S+GAS9%!+ 0(4
M Q0    ( !TXN%B5,ZR67 8  +]#   3              "  <<F  !G:"TR
M,#(T,#4R,U]L86(N>&UL4$L! A0#%     @ '3BX6+;6^XRX!   ?RH  !,
M             ( !5"T  &=H+3(P,C0P-3(S7W!R92YX;6Q02P4&      4
,!0 Z 0  /3(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>d843201d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gh-20240523.xsd" xlink:type="simple"/>
    <context id="duration_2024-05-23_to_2024-05-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001576280</identifier>
        </entity>
        <period>
            <startDate>2024-05-23</startDate>
            <endDate>2024-05-23</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-249">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-05-23_to_2024-05-23"
      id="Hidden_dei_EntityCentralIndexKey">0001576280</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-260">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-261">2024-05-23</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-262">GUARDANT HEALTH, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-263">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-264">001-38683</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-265">45-4139254</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-266">3100 Hanover Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-267">Palo Alto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-268">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-269">94304</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-270">855</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-271">698-8887</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-272">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-273">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-274">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-275">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-276">Common Stock, $0.00001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-277">GH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-278">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-05-23_to_2024-05-23" id="ixv-279">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
